Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 117 Thousand USD | -88.44% |
| 2014 | 1.01 Million USD | -15.88% |
| 2013 | 1.2 Million USD | -12.06% |
| 2012 | 1.36 Million USD | 12.04% |
| 2011 | 1.22 Million USD | -14.43% |
| 2010 | 1.42 Million USD | 43.72% |
| 2009 | 992.87 Thousand USD | 328.46% |
| 2008 | 231.73 Thousand USD | 308.54% |
| 2007 | 56.72 Thousand USD | -38.91% |
| 2006 | 92.85 Thousand USD | -54.91% |
| 2005 | 205.91 Thousand USD | 46.0% |
| 2004 | 141.03 Thousand USD | -48.42% |
| 2003 | 273.43 Thousand USD | -34.17% |
| 2002 | 415.37 Thousand USD | -48.42% |
| 2001 | 805.23 Thousand USD | 983.76% |
| 2000 | 74.3 Thousand USD | -98.52% |
| 1999 | 5.02 Million USD | -42.94% |
| 1998 | 8.8 Million USD | -16.98% |
| 1997 | 10.6 Million USD | 49.3% |
| 1996 | 7.1 Million USD | -39.83% |
| 1995 | 11.8 Million USD | 807.69% |
| 1994 | 1.3 Million USD | -56.67% |
| 1993 | 3 Million USD | 114.29% |
| 1992 | 1.4 Million USD | 180.0% |
| 1991 | 500 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | 142 Thousand USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 100.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | 29.31 Thousand USD | 26.54% |
| 2016 Q1 | 23.16 Thousand USD | -20.12% |
| 2016 FY | - USD | -100.0% |
| 2016 Q4 | -85.23 Thousand USD | -360.17% |
| 2016 Q3 | 32.76 Thousand USD | 11.77% |
| 2015 FY | 117 Thousand USD | -88.44% |
| 2015 Q2 | 30.13 Thousand USD | 43.5% |
| 2015 Q1 | 20.99 Thousand USD | -97.62% |
| 2015 Q3 | 37.03 Thousand USD | 22.9% |
| 2015 Q4 | 29 Thousand USD | -21.69% |
| 2014 Q4 | 883 Thousand USD | 228.25% |
| 2014 Q1 | 339.48 Thousand USD | 8.81% |
| 2014 Q3 | 269 Thousand USD | 11.06% |
| 2014 Q2 | 242.2 Thousand USD | -28.65% |
| 2014 FY | 1.01 Million USD | -15.88% |
| 2013 FY | 1.2 Million USD | -12.06% |
| 2013 Q2 | 281.69 Thousand USD | -0.88% |
| 2013 Q4 | 312 Thousand USD | -3.94% |
| 2013 Q3 | 324.79 Thousand USD | 15.3% |
| 2013 Q1 | 284.2 Thousand USD | 34.63% |
| 2012 Q2 | 249 Thousand USD | -61.34% |
| 2012 FY | 1.36 Million USD | 12.04% |
| 2012 Q4 | 211.09 Thousand USD | -20.04% |
| 2012 Q1 | 644.03 Thousand USD | 18.93% |
| 2012 Q3 | 263.99 Thousand USD | 6.02% |
| 2011 FY | 1.22 Million USD | -14.43% |
| 2011 Q1 | 221 Thousand USD | -68.39% |
| 2011 Q2 | 234 Thousand USD | 5.88% |
| 2011 Q3 | 223 Thousand USD | -4.7% |
| 2011 Q4 | 541.52 Thousand USD | 142.83% |
| 2010 Q2 | 244.13 Thousand USD | 6.02% |
| 2010 Q3 | 253.51 Thousand USD | 3.85% |
| 2010 Q1 | 230.27 Thousand USD | -44.86% |
| 2010 Q4 | 699.04 Thousand USD | 175.74% |
| 2010 FY | 1.42 Million USD | 43.72% |
| 2009 Q3 | 253.16 Thousand USD | -4.63% |
| 2009 FY | 992.87 Thousand USD | 328.46% |
| 2009 Q1 | 56.6 Thousand USD | -67.12% |
| 2009 Q4 | 417.64 Thousand USD | 64.97% |
| 2009 Q2 | 265.45 Thousand USD | 368.97% |
| 2008 Q4 | 172.16 Thousand USD | 1290.82% |
| 2008 Q3 | 12.37 Thousand USD | -58.5% |
| 2008 Q2 | 29.83 Thousand USD | 71.94% |
| 2008 Q1 | 17.35 Thousand USD | -41.73% |
| 2008 FY | 231.73 Thousand USD | 308.54% |
| 2007 Q2 | 7840.00 USD | 31.85% |
| 2007 Q1 | 5946.00 USD | -52.22% |
| 2007 Q3 | 13.16 Thousand USD | 67.88% |
| 2007 Q4 | 29.77 Thousand USD | 126.21% |
| 2007 FY | 56.72 Thousand USD | -38.91% |
| 2006 FY | 92.85 Thousand USD | -54.91% |
| 2006 Q1 | 41.55 Thousand USD | -2.39% |
| 2006 Q4 | 12.44 Thousand USD | -32.08% |
| 2006 Q3 | 18.32 Thousand USD | -10.78% |
| 2006 Q2 | 20.53 Thousand USD | -50.58% |
| 2005 FY | 205.91 Thousand USD | 46.0% |
| 2005 Q4 | 42.56 Thousand USD | -53.35% |
| 2005 Q3 | 91.25 Thousand USD | 148.18% |
| 2005 Q2 | 36.76 Thousand USD | 4.1% |
| 2005 Q1 | 35.32 Thousand USD | -5.97% |
| 2004 FY | 141.03 Thousand USD | -48.42% |
| 2004 Q2 | 5837.00 USD | -93.73% |
| 2004 Q3 | 4541.00 USD | -22.2% |
| 2004 Q4 | 37.56 Thousand USD | 727.22% |
| 2004 Q1 | 93.09 Thousand USD | -23.31% |
| 2003 Q1 | 58.95 Thousand USD | -33.81% |
| 2003 Q4 | 121.39 Thousand USD | 270.2% |
| 2003 Q3 | 32.79 Thousand USD | -45.62% |
| 2003 FY | 273.43 Thousand USD | -34.17% |
| 2003 Q2 | 60.29 Thousand USD | 2.28% |
| 2002 Q2 | 125.32 Thousand USD | 12.61% |
| 2002 Q4 | 89.06 Thousand USD | -0.69% |
| 2002 Q1 | 111.29 Thousand USD | -13.52% |
| 2002 FY | 415.37 Thousand USD | -48.42% |
| 2002 Q3 | 89.68 Thousand USD | -28.44% |
| 2001 Q1 | 100 Thousand USD | 34.59% |
| 2001 Q4 | 128.69 Thousand USD | -53.46% |
| 2001 FY | 805.23 Thousand USD | 983.76% |
| 2001 Q3 | 276.53 Thousand USD | -7.82% |
| 2001 Q2 | 300 Thousand USD | 200.0% |
| 2000 Q2 | 1.00 USD | 0.0% |
| 2000 Q3 | 1.00 USD | 0.0% |
| 2000 Q4 | 74.29 Thousand USD | 7429800.0% |
| 2000 FY | 74.3 Thousand USD | -98.52% |
| 2000 Q1 | 1.00 USD | -100.0% |
| 1999 Q3 | 100 Thousand USD | -96.0% |
| 1999 FY | 5.02 Million USD | -42.94% |
| 1999 Q1 | 2.5 Million USD | 0.0% |
| 1999 Q2 | 2.5 Million USD | 0.0% |
| 1999 Q4 | 21.7 Thousand USD | -78.29% |
| 1998 FY | 8.8 Million USD | -16.98% |
| 1998 Q4 | 2.5 Million USD | 0.0% |
| 1998 Q3 | 2.5 Million USD | 31.58% |
| 1998 Q2 | 1.9 Million USD | 5.56% |
| 1998 Q1 | 1.8 Million USD | -5.26% |
| 1997 FY | 10.6 Million USD | 49.3% |
| 1997 Q4 | 1.9 Million USD | 5.56% |
| 1997 Q3 | 1.8 Million USD | -64.71% |
| 1997 Q2 | 5.1 Million USD | 168.42% |
| 1997 Q1 | 1.9 Million USD | 5.56% |
| 1996 FY | 7.1 Million USD | -39.83% |
| 1996 Q3 | 1.8 Million USD | -5.26% |
| 1996 Q2 | 1.9 Million USD | 11.76% |
| 1996 Q1 | 1.7 Million USD | -15.0% |
| 1996 Q4 | 1.8 Million USD | 0.0% |
| 1995 Q2 | 1.5 Million USD | -76.19% |
| 1995 FY | 11.8 Million USD | 807.69% |
| 1995 Q1 | 6.3 Million USD | 0.0% |
| 1995 Q4 | 2 Million USD | 0.0% |
| 1995 Q3 | 2 Million USD | 33.33% |
| 1994 Q2 | 100 Thousand USD | -92.31% |
| 1994 FY | 1.3 Million USD | -56.67% |
| 1994 Q1 | 1.3 Million USD | -38.1% |
| 1994 Q4 | - USD | -100.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q2 | 300 Thousand USD | 200.0% |
| 1993 Q3 | 200 Thousand USD | -33.33% |
| 1993 Q4 | 2.1 Million USD | 950.0% |
| 1993 FY | 3 Million USD | 114.29% |
| 1993 Q1 | 100 Thousand USD | -75.0% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 FY | 1.4 Million USD | 180.0% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 400 Thousand USD | 100.0% |
| 1992 Q4 | 400 Thousand USD | 0.0% |
| 1991 FY | 500 Thousand USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q4 | 200 Thousand USD | 100.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 100.0% |
| AngioDynamics, Inc. | 303.91 Million USD | 100.0% |
| AtriCure, Inc. | 399.24 Million USD | 100.0% |
| Avinger, Inc. | 7.65 Million USD | 100.0% |
| Azenta, Inc. | 665.07 Million USD | 100.0% |
| BioLife Solutions, Inc. | 143.27 Million USD | 100.0% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 100.0% |
| Daxor Corporation | 1.28 Million USD | 100.0% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | 100.0% |
| Femasys Inc. | 1.07 Million USD | 100.0% |
| GlucoTrack, Inc. | - USD | NaN% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 100.0% |
| Hologic, Inc. | 4.03 Billion USD | 100.0% |
| ICU Medical, Inc. | 2.25 Billion USD | 100.0% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 100.0% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 100.0% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 100.0% |
| Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
| Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
| Masimo Corporation | 2.04 Billion USD | 100.0% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 100.0% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 100.0% |
| Nephros, Inc. | 14.23 Million USD | 100.0% |
| NovoCure Limited | 509.33 Million USD | 100.0% |
| NEXGEL, Inc. | 4.08 Million USD | 100.0% |
| NEXGEL, Inc. | 4.08 Million USD | 100.0% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | 100.0% |
| OraSure Technologies, Inc. | 405.47 Million USD | 100.0% |
| Pro-Dex, Inc. | 53.84 Million USD | 100.0% |
| Pulse Biosciences, Inc. | - USD | NaN% |
| Predictive Oncology Inc. | 1.78 Million USD | 100.0% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | 100.0% |
| QuidelOrtho Corporation | 2.99 Billion USD | 100.0% |
| Repligen Corporation | 638.76 Million USD | 100.0% |
| Sanara MedTech Inc. | 64.98 Million USD | 100.0% |
| STAAR Surgical Company | 322.41 Million USD | 100.0% |
| Sharps Technology, Inc. | - USD | NaN% |
| Utah Medical Products, Inc. | 50.22 Million USD | 100.0% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 100.0% |
| Jin Medical International Ltd. | 19.82 Million USD | 100.0% |